TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 4 | 1 | -1 | 1 | 28 | 61 | 63 | 25 |
| P | %wins | 25 | 75 | 75 | 25 | 50 | 50 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/13/24 18:01 | 1/23/24 | LBPH | Longboard Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Kaye Randall | CA | O | CMO | P.d | 2 | 24.82 | 0 | 0 | 0 | 36 | M | |||||||||||||||
12/24/15 13:02 | 12/23/15 | AXSM | Axsome Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kaye Randall | NY | O | Chief Me | P | 9 | 9.03 | 1 | 1 | 20 | 6 | I | 4 | 9 | -2 | -3 | 3 | 29 | -9 | -21 | -26 | |||||
9/15/09 21:18 | 9/11/09 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kaye Randall | CA | O | SVP,Chie | P | 4 | 2.18 | 4 | 2 | 1 | 398 | I | -4 | 145 | 380 | 39 | 3 | 14 | 13 | 9 | -1 | 0 | 0 | -13 | 0 | 27 |
2/25/09 15:37 | 2/23/09 | AVNR | Avanir Pharmaceuticals | CA | Health | Drug | Pharmaceutical Preparations | Kaye Randall | CA | O | SVP,Chie | P | 4 | 0.4263 | 0 | 10 | 2 | 426 | S | -2 | -11 | 0 | 150 | 332 | 316 | ||||||||
5/26/06 14:41 | 5/26/06 | AVNR | Avanir Pharmaceuticals | CA | Health | Drug | Pharmaceutical Preparations | Kaye Randall | CA | O | VP of Me | P | 25 | 10.09 | 4 | 3 | 200 | 4 | b | 10 | 5 | -27 | -16 | -67 | -65 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |